Levomefolic acid (INN) is the metabolite of folic acid (Vitamin B9) and it is a predominant active form of folate found in foods and in the blood circulation, accounting for 98% of folates in human plasma [A19276]. It is transported across the membranes including the blood-brain barrier into various tissues where it plays an essential role in the DNA synthesis, cysteine cycle and regulation of homocysteine, where it methylates homocysteine and forms methionine and tetrahydrofolate (THF). Levomefolate is approved as a food additive and is designated a GRAS (generally regarded as safe) compound [L773]. It is available commercially as a crystalline form of the calcium salt (Metafolin(R)), which has the stability required for use as a supplement [A19276]. Supplementation of levomefolic acid is desired over folic acid due to reduced potential for masking vitamin B12 deficiency symptoms.
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calcium
Hematron-AF
L-Methyl PNV DHA
Biopar delta-FORTE
Quflora FE
Quflora FE Pediatric Drops
Rulavite DHA
Select OB
PreGenna
Rajani
Tricare Prenatal Quick Dissolve
PramLyte
Maxaron Forte
Davimet with Iron
L-Methyl-MC-NAC
Davimet with Fluoride
L-Methyl MC
Quflora Pediatric Drops
L-Methylfolate Calcium
Levomefolate Calcium Acetylcysteine and Mecobalamin Algal
Yaz Plus
Medi-10
Tendera-OB
Levomefolate Calcium, Cyanocobalamin and Pyridoxine Hydrochloride
Davimet-M
Hemax
Prenatol-M
Tricare Prenatal DHA One With Folate
OBTREX DHA Combo Pack
Levomefolate Calcium and Schizochytrium DHA
Inflamex
Obtrex One
Denovo
Zatean-Pn Plus
Livita Adults
Zatean-Pn
Florravite
Virt-PN Plus
Obstetrix ONE
Vitafol Ultra
MaxFe
TriStart DHA
L-Methyl-B6-B12
Levomefolate Calcium and Algal
Indication
For the treatment and prevention of folate deficiency and for use as an antidote against folic acid antagonists. Contained in oral contraceptives to reduce the risk of neural tube defects arising from folic acid deficiency for pregnant women who conceived during use or shortly after the discontinuation of the product. Being studied for use as a treatment for cardiovascular diseases [A19273] and adjunct therapy for patients undergoing antidepressant pharmacotherapy [A19271, A19272].
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682